Innovative cancer research focused on radiation therapy
Official title: Developmental Research Program
Funded at University of Michigan at Ann Arbor · NIH-10917049 · Data updated 2026-11-12
This study is all about finding new and better ways to use radiation therapy to treat cancer, and it's for researchers at the University of Michigan who want to explore fresh ideas that could help improve care for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | August 14, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $141,991 |
| NIH project number | 5P50CA269022-02 |
| Project ID | NIH-10917049 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients with locally advanced cancer who may benefit from innovative radiation therapy approaches.
✕Less likely to help
Patients with cancers that are not amenable to radiation therapy may not receive benefit from this research.
What this research studies
This research program supports innovative projects aimed at improving radiation therapy for cancer treatment. It provides funding for multiple developmental research projects, allowing investigators to explore new ideas and gather preliminary data that could lead to significant advancements in cancer care. The program encourages collaboration among University of Michigan faculty and aims to foster groundbreaking initiatives that can translate into effective treatments for patients. Each project is expected to receive funding for one year, with a total of 10-15 projects supported over the five-year grant period.
Why it matters
Potential benefit: If successful, this research could lead to improved radiation therapy techniques that enhance treatment outcomes for cancer patients.
How similar studies have gone: Previous research in radiation therapy has shown promising results, indicating that innovative approaches can lead to significant improvements in patient outcomes.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Fearon, Eric R. — University of Michigan at Ann Arbor
- Study coordinator: Fearon, Eric R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.